From Proteopedia
			
												
			proteopedia linkproteopedia link
The Pharmaceutical industry is one of the world’s largest industries, grossing well over $300 billion in the United States alone. Understanding how the drugs the pharma industry develops work and different characteristics of these compounds is important to nearly everyone as 50% of the US population takes at least one prescription medication regularly and nearly everyone takes a pharmaceutical pill at some point in their life.[1] See also WHO Model Lists of Essential Medicines. The following is a growing list of pharmaceutical compounds organized by disorder. 
See Pharmaceutical Drug Targets for a list of drug targets organized by disease. 
The majority of all modern medicinal drugs target members of the superfamily of proteins called the G protein-coupled receptors or GPCRs[2][3].
 Treatments
The following is a list of pharmaceutical treatments for various diseases, organized by disorder. Each entry highlights general information about the therapeutic, pharmacokinetic data comparisons within its drug class, and a structural analysis explaining how the drug compound functions in vivo.
 
|  |  |  | 
| 
 
|  Antagonists at glutamatergic NMDA receptors |  |  | 
 
| See Treatment of multiple myeloma
  Anti-prostate cancer Anti-myeloma Anti-acute lymphocytic leukemia Anti-non-small cell lung cacinoma B-Raf Kinase Inhibitor Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
  Chemotherapy Estrogen Receptor Modulator mTOR inhibitor Rapamune - Generic: Sirolimus (Rapamycin)
 Afinitor - Generic: Everolimus
 Torisel - Generic: Temsirolimus
  Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl, RAF kinase) InhibitorsSee Treatment of chronic myelogenous leukemia, Treatment of hepatocellular carcinoma, Treatment of renal cell carcinoma, Treatment of gastrointestinal stromal tumor, VEGFR inhibitors and Tyrosine-kinase inhibitors.
  Poly ADP ribose polymerase (PARP) inhibitorsSee also Anti-cancer drugs, Anticancer drugs and RAF kinase inhibitors
 |  | 
|  Depression |  |  Erectile Dysfunction | 
| 
 
|  Tricyclic Antidepressants Selective Serotonin Reuptake Inhibitors Serotonin–norepinephrine reuptake inhibitor Serotonin–dopamine reuptake inhibitorSee Atypical antipsychotics
 |  
 | 
 
|  Mechanism is not completely understood Inhibitors of the sodium glucose co-transporter-2 (SGLT-2) |  | 
 
|  Phosphodiesterase Type 5 Inhibitor Cialis - Generic: Tadalafil
 Levitra - Generic: Vardenafil
 Viagra - Generic: Sildenafil
 |  | 
|  |  |  | 
| 
 
|  Niemann-Pick C1-like 1 (NPC1L1) protein blocker |  | 
 
|  Inhibitors of neprilysin Renin inhibitors Angiotensin II receptor antagonist |  | 
 
|  Chemokine Receptor Type 5 (CCR5) Inhibitors Selzentry - Generic: Maraviroc
  Baraclude - Generic: Entecavir
 Emtriva - Generic: Emtricitabine
 Epivir - Generic: Lamivudine
 Hivid - Generic: Zalcitabine
 Retrovir - Generic: Zidovudine
 Videx - Generic: Didanosine
 Viread - Generic: Tenofovir
 Zerit - Generic: Stavudine
 Ziagen - Generic: Abacavir
  Cytochrome P450 inhibitors Combinations |  
 | 
|  |  |  | 
| 
 
|  Voltaren - Generic: Diclofenac also may inhibit phospholipase A2 as part of its mechanism of action.
 |  |  | 
 
|  MScontin, Oramorph, Sevredol - Generic: Morphine (opioid receptor agonist)
 Demerol - Generic: Meperidine (opioid receptor agonist)
 Dolophine - Generic: Methadone (Levomethadone (the R enantiomer) is a opioid receptor agonist)
 Actiq, Duragesic, Fentora - Generic: Fentanyl (opioid receptor agonist)
  Narcan - Generic: Naloxone (competitive opioid receptor antagonist)
 ReVia - Generic: Naltrexone (competitive opioid receptor antagonist)
 Entereg - Generic: Alvimopan (opioid receptor antagonist)
 |  | 
 Viral diseases |  Asthma |  Various diseases | 
| 
 
|  Anti-viral RNA synthesis Anti-chickenpox and cytomegalovirus infection and herpes and shingles |  |  | 
 
|  Anti-swellingVoltage-gated sodium (Nav) channel inhibitors
  Anti-epilepsyVoltage-gated sodium (Nav) channel inhibitors
  Anti-psoriasis Anti-glaucoma and mountain sickness Anti-gastroesophageal reflux diseseH/K transporting ATPase inhibitor
  Local anesthetic |  | 
 References
- ↑ http://www.npr.org/blogs/health/2010/09/03/129626052/a-portrait-of-health-prescription-drugs-in-america
- ↑ Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. PMID:17139284 doi:10.1038/nrd2199
- ↑ Peeters MC, van Westen GJ, Li Q, IJzerman AP. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends Pharmacol Sci. 2011 Jan;32(1):35-42. PMID:21075459 doi:10.1016/j.tips.2010.10.001